J Gen Virol Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

J Gen Virol 78 (1997), 1935-1939
© 1997 Society for General Microbiology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Astori, M.
Right arrow Articles by Karapetian, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Astori, M.
Right arrow Articles by Karapetian, O.
Agricola
Right arrow Articles by Astori, M.
Right arrow Articles by Karapetian, O.

Journal of General Virology, Vol 78, 1935-1939, Copyright © 1997 by Society for General Microbiology

ARTICLES

Immunization with a mouse mammary tumour virus envelope protein epitope protects against tumour formation without inhibition of the virus infection

M Astori and O Karapetian
Swiss Institute for Experimental Cancer Research and Institute of Biochemistry, University of Lausanne, Epalinges. mastori@eliot.unil.ch

BALB/c mice were immunized with the EP3 surface epitope of the mouse mammary tumour virus (MMTV) gp52 envelope protein before systemic infection with MMTV(C3H) or MMTV(SW). Analysis of the successive stages of the virus infection showed that although these mice were protected against mammary tumour formation, earlier stages of the infection were not inhibited, as reflected by the persisting superantigen-induced activation and deletion of Vbeta-specific T cells. Transplacental transfer of maternal anti-EP3 immunoglobulins to newborns did not protect them from infection through the Peyer's patches. Preincubation of the MMTVs with an anti-EP3 serum before injection, however, successfully inhibited the early stages of the infection. Results from this study show that to inhibit infection by MMTV efficiently, the virus must be neutralized before its interaction with the cell membrane, and that the affinity of the virus-membrane interaction is higher than that of the virus-antibody interaction.


This article has been cited by other articles:


Home page
 Clin. Cancer Res.Home page
P. R. Etkind, A. F. R. Stewart, T. Dorai, D. J. Purcell, and P. H. Wiernik
Clonal Isolation of Different Strains of Mouse Mammary Tumor Virus-Like DNA Sequences from Both the Breast Tumors and Non-Hodgkin's Lymphomas of Individual Patients Diagnosed with Both Malignancies
Clin. Cancer Res., September 1, 2004; 10(17): 5656 - 5664.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
M. Mpandi, L. A. Otten, C. Lavanchy, H. Acha-Orbea, and D. Finke
Passive Immunization with Neutralizing Antibodies Interrupts the Mouse Mammary Tumor Virus Life Cycle
J. Virol., September 1, 2003; 77(17): 9369 - 9377.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
D. Finke, S. A. Luther, and H. Acha-Orbea
The role of neutralizing antibodies for mouse mammary tumor virus transmission and mammary cancer development
PNAS, January 7, 2003; 100(1): 199 - 204.
[Abstract] [Full Text] [PDF]

Home page
 J. Gen. Virol.Home page
M Astori and O Karapetian
Antibodies to the C-terminal dipeptide of mouse mammary tumor virus [MMTV(SW)] superantigen effectively inhibit T-cell activation in vivo
J. Gen. Virol., January 1, 1998; 79(1): 57 - 60.
[Abstract]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 1997 by the Society for General Microbiology.